Biohaven is a startup based in the United States, most recent round Pre-ipo, 1 tracked investor.
Biohaven is a company headquartered in the United States. Its most recent tracked round is Pre-ipo. Brouky records 1 investor associated with the company.
Biohaven is a clinical-stage biopharmaceutical company developing treatments for diseases in immunology, neuroscience, oncology, and obesity, including migraine therapies and novel precision immunology drugs.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.